These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7501050

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
    Chiu CH, McEntee MF, Whelan J.
    Cancer Res; 1997 Oct 01; 57(19):4267-73. PubMed ID: 9331087
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
    Wechter WJ, Kantoci D, Murray ED, Quiggle DD, Leipold DD, Gibson KM, McCracken JD.
    Cancer Res; 1997 Oct 01; 57(19):4316-24. PubMed ID: 9331093
    [Abstract] [Full Text] [Related]

  • 6. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
    Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA.
    Cancer Res; 2000 Sep 15; 60(18):5040-4. PubMed ID: 11016626
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice.
    Hansen-Petrik MB, McEntee MF, Jull B, Shi H, Zemel MB, Whelan J.
    Cancer Res; 2002 Jan 15; 62(2):403-8. PubMed ID: 11809688
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
    Florent C, Meary N.
    Bull Cancer; 2004 May 15; 91 Spec No():S85-8. PubMed ID: 15239335
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The inhibiting effect of ortofen and dexamethasone on the development of tumors of the cervix uteri and vagina].
    Bespalov VG, Aleksandrov VA, Troian DN, Lidak MIu.
    Farmakol Toksikol; 1990 May 15; 53(4):49-51. PubMed ID: 2121519
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
    Strul H, Arber N.
    Isr Med Assoc J; 2000 Sep 15; 2(9):695-702. PubMed ID: 11062772
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. From the Food and Drug Administration.
    Henney JE.
    JAMA; 2000 Mar 01; 283(9):1131. PubMed ID: 10703765
    [No Abstract] [Full Text] [Related]

  • 19. Combinatorial chemoprevention of intestinal neoplasia.
    Torrance CJ, Jackson PE, Montgomery E, Kinzler KW, Vogelstein B, Wissner A, Nunes M, Frost P, Discafani CM.
    Nat Med; 2000 Sep 01; 6(9):1024-8. PubMed ID: 10973323
    [Abstract] [Full Text] [Related]

  • 20. Discordant effect of aspirin and indomethacin on intestinal tumor burden in Apc(Min/+)mice.
    Chiu CH, McEntee MF, Whelan J.
    Prostaglandins Leukot Essent Fatty Acids; 2000 May 01; 62(5):269-75. PubMed ID: 10883057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.